Literature DB >> 20160087

Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins.

Haopeng Rui1, Jennifer M Ritchie, Roderick T Bronson, John J Mekalanos, Yuanxing Zhang, Matthew K Waldor.   

Abstract

Cholera is a severe diarrheal disease caused by the motile Gram-negative rod Vibrio cholerae. Live-attenuated V. cholerae vaccines harboring deletions of the genes encoding cholera toxin have great promise for reducing the global burden of cholera. However, development of live vaccines has been hampered by the tendency of such strains to induce noncholeric reactogenic diarrhea in human subjects. The molecular bases of reactogenicity are unknown, but it has been speculated that reactogenic diarrhea is a response to V. cholerae's flagellum and/or the motility that it enables. Here, we used an infant rabbit model of reactogenicity to determine what V. cholerae factors trigger this response. We found that V. cholerae ctx mutants that produced flagellins induced diarrhea, regardless of whether the proteins were assembled into a flagellum or whether the flagellum was functional. In contrast, approximately 90% of rabbits infected with V. cholerae lacking all five flagellin-encoding genes did not develop diarrhea. Thus, flagellin production, independent of flagellum assembly or motility, is sufficient for reactogenicity. The intestinal colonization and intraintestinal localization of the nonreactogenic flagellin-deficient strain were indistinguishable from those of a flagellated motile strain; however, the flagellin-deficient strain stimulated fewer mRNA transcripts coding for proinflammatory cytokines in the intestine. Thus, reactogenic diarrhea may be a consequence of an innate host inflammatory response to V. cholerae flagellins. Our results suggest a simple genetic blueprint for engineering defined nonreactogenic live-attenuated V. cholerae vaccine strains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160087      PMCID: PMC2840140          DOI: 10.1073/pnas.0915164107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Directed polar secretion of protease from single cells of Vibrio cholerae via the type II secretion pathway.

Authors:  M E Scott; Z Y Dossani; M Sandkvist
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Cholera vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2001-04-20

4.  Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease.

Authors:  Michelle Dziejman; Emmy Balon; Dana Boyd; Clare M Fraser; John F Heidelberg; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

5.  Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development.

Authors:  J J Mekalanos; D J Swartz; G D Pearson; N Harford; F Groyne; M de Wilde
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

6.  Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.

Authors:  T Ramamurthy; S Garg; R Sharma; S K Bhattacharya; G B Nair; T Shimada; T Takeda; T Karasawa; H Kurazano; A Pal
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

Review 7.  Cholera vaccines: fighting an ancient scourge.

Authors:  J J Mekalanos; J C Sadoff
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

8.  Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut.

Authors:  F Qadri; T R Bhuiyan; K K Dutta; R Raqib; M S Alam; N H Alam; A-M Svennerholm; M M Mathan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 9.  Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.

Authors:  Mohiul Islam Chowdhury; Alaullah Sheikh; Firdausi Qadri
Journal:  Expert Rev Vaccines       Date:  2009-12       Impact factor: 5.217

10.  The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model.

Authors:  Karla Jean Fullner; John C Boucher; Martha A Hanes; G Kenneth Haines; Brian M Meehan; Cynthia Walchle; Philippe J Sansonetti; John J Mekalanos
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  35 in total

Review 1.  Mechanisms of Cholera Toxin in the Modulation of TH17 Responses.

Authors:  Hsing-Chuan Tsai; Reen Wu
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

2.  Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.

Authors:  Anne L Bishop; Bharathi Patimalla; Andrew Camilli
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation.

Authors:  Amy T Ma; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-11       Impact factor: 11.205

4.  Vibrio crassostreae, a benign oyster colonizer turned into a pathogen after plasmid acquisition.

Authors:  Maxime Bruto; Adèle James; Bruno Petton; Yannick Labreuche; Sabine Chenivesse; Marianne Alunno-Bruscia; Martin F Polz; Frédérique Le Roux
Journal:  ISME J       Date:  2016-12-06       Impact factor: 10.302

5.  Quantifying Vibrio cholerae Enterotoxicity in a Zebrafish Infection Model.

Authors:  Kristie C Mitchell; Paul Breen; Sarah Britton; Melody N Neely; Jeffrey H Withey
Journal:  Appl Environ Microbiol       Date:  2017-08-01       Impact factor: 4.792

6.  A high-throughput screening assay for inhibitors of bacterial motility identifies a novel inhibitor of the Na+-driven flagellar motor and virulence gene expression in Vibrio cholerae.

Authors:  Lynn Rasmussen; E Lucile White; Ashish Pathak; Julio C Ayala; Hongxia Wang; Jian-He Wu; Jorge A Benitez; Anisia J Silva
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

7.  Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection.

Authors:  Jessica Queen; Karla J Fullner Satchell
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

8.  Novel cholix toxin variants, ADP-ribosylating toxins in Vibrio cholerae non-O1/non-O139 strains, and their pathogenicity.

Authors:  Sharda Prasad Awasthi; Masahiro Asakura; Nityananda Chowdhury; Sucharit Basu Neogi; Atsushi Hinenoya; Hossain M Golbar; Jyoji Yamate; Eiji Arakawa; Toshiji Tada; T Ramamurthy; Shinji Yamasaki
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

9.  Tracking Vibrio cholerae Cell-Cell Interactions during Infection Reveals Bacterial Population Dynamics within Intestinal Microenvironments.

Authors:  Yang Fu; Brian T Ho; John J Mekalanos
Journal:  Cell Host Microbe       Date:  2018-02-02       Impact factor: 21.023

Review 10.  Vibrio cholerae hemagglutinin(HA)/protease: An extracellular metalloprotease with multiple pathogenic activities.

Authors:  Jorge A Benitez; Anisia J Silva
Journal:  Toxicon       Date:  2016-03-04       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.